These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11565264)

  • 21. B-cell enrichment and infusion in CD4+/CD8+ T-cell depleted products for donor innate immune lymphocyte infusion: is risk of EBV-associated lymphocyte post transplantation lymphoproliferative disease a concern?
    Lamb LS; Sande J
    Bone Marrow Transplant; 2008 Jun; 41(11):995-6. PubMed ID: 18278072
    [No Abstract]   [Full Text] [Related]  

  • 22. Fine-needle aspiration cytology of lymphoproliferative disorders in the immunosuppressed patient: the diagnostic utility of in situ hybridization for Epstein-Barr virus.
    Hecht JL; Cibas ES; Kutok JL
    Diagn Cytopathol; 2002 Jun; 26(6):360-5. PubMed ID: 12112825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
    J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.
    Merlo A; Turrini R; Bobisse S; Zamarchi R; Alaggio R; Dolcetti R; Mautner J; Zanovello P; Amadori A; Rosato A
    J Immunol; 2010 May; 184(10):5895-902. PubMed ID: 20385879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell-mediated control of Epstein-Barr virus infection in humanized mice.
    Yajima M; Imadome K; Nakagawa A; Watanabe S; Terashima K; Nakamura H; Ito M; Shimizu N; Yamamoto N; Fujiwara S
    J Infect Dis; 2009 Nov; 200(10):1611-5. PubMed ID: 19832115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H
    Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patient.
    Leaver S; Amlot P; Thuraisingham R; Norton A; Aitken C; Cavenagh JD
    Clin Lab Haematol; 2004 Oct; 26(5):351-3. PubMed ID: 15485466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease.
    Guppy AE; Rawlings E; Madrigal JA; Amlot PL; Barber LD
    Transplantation; 2007 Dec; 84(11):1534-9. PubMed ID: 18091531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fulminant Epstein-Barr virus-driven CD8 positive T-cell lymphoproliferative disorder with chromosomal abnormality.
    Tanoshima R; Goto H; Kato H; Yokosuka T; Kajiwara R; Yokota S
    Pediatr Blood Cancer; 2011 Jul; 57(1):182. PubMed ID: 21445947
    [No Abstract]   [Full Text] [Related]  

  • 33. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder.
    Kuzushima K; Kimura H; Hoshino Y; Yoshimi A; Tsuge I; Horibe K; Morishima T; Tsurumi T; Kojima S
    J Infect Dis; 2000 Sep; 182(3):937-40. PubMed ID: 10950793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the T-cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease.
    Perera SM; Thomas JA; Burke M; Crawford DH
    J Pathol; 1998 Feb; 184(2):177-84. PubMed ID: 9602709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations among Epstein-Barr virus subtypes, human leukocyte antigen class I alleles, and the development of posttransplantation lymphoproliferative disorder in bone marrow transplant recipients.
    Görzer I; Puchhammer-Stöckl E; van Esser JW; Niesters HG; Cornelissen JJ
    Clin Infect Dis; 2007 Mar; 44(5):693-5. PubMed ID: 17278061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon gamma (IFN-gamma) deficiency in generalized Epstein-Barr virus infection with interstitial lymphoid and granulomatous pneumonia, focal cerebral lesions, and genital ulcers: remission following IFN-gamma substitution therapy.
    Andersson J; Isberg B; Christensson B; Veress B; Linde A; Bratel T
    Clin Infect Dis; 1999 May; 28(5):1036-42. PubMed ID: 10452631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
    Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epstein-Barr virus positive T/NK-cell lymphoproliferative disease: the pathogenesis and target cells of infection].
    Ohga S
    Fukuoka Igaku Zasshi; 2011 Mar; 102(3):41-7. PubMed ID: 21634214
    [No Abstract]   [Full Text] [Related]  

  • 40. Epstein-Barr virus associated disease following blood or marrow transplant.
    Gross TG; Loechelt BJ
    Pediatr Transplant; 2003; 7 Suppl 3():44-50. PubMed ID: 12603692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.